Parotid Gland Cancer
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer (NCT00405405) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2006-12-01 |
Track Parotid Gland Cancer automatically
Every clearance here is in the API, with alerts when new ones post.